Digoxin and xamoterol in patients with moderate chronic heart failure. A double-blind, randomized, controlled study

1989 ◽  
Vol 3 (2) ◽  
pp. 203-209 ◽  
Author(s):  
E. Vigholt Sorensen ◽  
Bent Sterndorff ◽  
M. Friis Andersen ◽  
Ole Faergeman
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Randomized Controlled Study ◽  
Controlled Study ◽  
Double Blind ◽  
Randomized Controlled

Long-term Atorvastatin Therapy might Reduce the Incidence of Ventricular Late Potentials in Patients with Chronic Heart Failure: A Prospective Randomized Controlled Study

2007 ◽  
Vol 13 (6) ◽  
pp. S53
Author(s):  
Takahisa Yamada ◽  
Yuji Okuyama ◽  
Takashi Morita ◽  
Yoshirou Furukawa ◽  
Yasumasa Tsukamoto ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Randomized Controlled Study ◽  
Controlled Study ◽  
Late Potentials ◽  
Ventricular Late Potentials ◽  
Randomized Controlled ◽  
Atorvastatin Therapy

scholarly journals A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease

2016 ◽  
Vol 37 (27) ◽  
pp. 2105-2114 ◽  
Author(s):  
Gerasimos Filippatos ◽  
Stefan D. Anker ◽  
Michael Böhm ◽  
Mihai Gheorghiade ◽  
Lars Køber ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Heart Failure ◽  
Chronic Kidney Disease ◽  
Chronic Heart Failure ◽  
Kidney Disease ◽  
Randomized Controlled Study ◽  
Controlled Study ◽  
Randomized Controlled

Functional and psychosocial effects of either a traditional dancing or a formal exercising training program in patients with chronic heart failure: a comparative randomized controlled study

2013 ◽  
Vol 28 (2) ◽  
pp. 128-138 ◽  
Author(s):  
Antonia CH Kaltsatou ◽  
Evangelia I Kouidi ◽  
Maria A Anifanti ◽  
Stella I Douka ◽  
Asterios P Deligiannis
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Training Program ◽  
Randomized Controlled Study ◽  
Controlled Study ◽  
Psychosocial Effects ◽  
Randomized Controlled

Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: A prospective randomized controlled study

2007 ◽  
Vol 153 (6) ◽  
pp. 1055.e1-1055.e8 ◽  
Author(s):  
Takahisa Yamada ◽  
Koichi Node ◽  
Takanao Mine ◽  
Takashi Morita ◽  
Hidetaka Kioka ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Cardiac Function ◽  
Term Effect ◽  
Randomized Controlled Study ◽  
Controlled Study ◽  
Randomized Controlled ◽  
Long Term Effect ◽  
Neurohumoral Activation

scholarly journals A Randomized Controlled Study of Finerenone vs. Eplerenone in Japanese Patients With Worsening Chronic Heart Failure and Diabetes and/or Chronic Kidney Disease

2016 ◽  
Vol 80 (5) ◽  
pp. 1113-1122 ◽  
Author(s):  
Naoki Sato ◽  
Masayoshi Ajioka ◽  
Takahisa Yamada ◽  
Masaharu Kato ◽  
Masafumi Myoishi ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Kidney Disease ◽  
Chronic Heart Failure ◽  
Kidney Disease ◽  
Japanese Patients ◽  
Randomized Controlled Study ◽  
Controlled Study ◽  
Randomized Controlled

Efficacy of Cardiac Rehabilitation with Assistance from Hybrid Assistive Limb in Patients with Chronic Heart Failure: Protocol for a Randomized Controlled Study

Cardiology ◽  
2019 ◽  
Vol 142 (4) ◽  
pp. 213-219
Author(s):  
Hiroki Watanabe ◽  
Akira Koike ◽  
Longmei Wu ◽  
Hidenori Kato ◽  
Hirotomo Konno ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Cardiac Rehabilitation ◽  
Exercise Therapy ◽  
Randomized Controlled Study ◽  
Thigh Muscle ◽  
Walking Distance ◽  
Controlled Study ◽  
Randomized Controlled ◽  
Hybrid Assistive Limb

The hybrid assistive limb (HAL) provides motion assistance based on bioelectrical signals detected on the skin surface when muscle forces are generated. The lumbar-type HAL is expected to expand the therapeutic options for severe cardiac patients who have difficulty in moving on their own legs. We aim to compare the efficacy of exercise therapy performed with assistance from a lumbar-type HAL versus conventional training (sit-to-stand exercise without HAL) in patients with chronic heart failure. This investigation will be a randomized, nonblinded, controlled study. Sixty patients who satisfy the criteria to receive cardiac rehabilitation therapy under the Japanese national insurance system will be enrolled at the University of Tsukuba Hospital. Participants randomly assigned to 2 groups (HAL group and conventional group) at a 1:1 allocation ratio will perform exercise therapy either with HAL or without HAL for 5–30 min once a day for 6–10 days. Outcome parameters will be measured just before and after the completion of the exercise therapy and at 1 year after hospital discharge. The primary outcomes will be the heart rate, blood pressure, subjective ratings of exercise intensity during exercise (Borg scale), number of days from the start of exercise therapy to independent walking and to discharge, and prognosis (mortality and cardiovascular events) over the 1-year period after discharge. The secondary outcomes will be the assessment of heart failure severity, brain natriuretic peptide, grip strength, thigh muscle thickness, isometric knee extensor strength, standing ability, 10-meter walking speed, 6-min walking distance, short physical performance battery, and adverse events. Unpaired t tests will be used for baseline assessments and outcome measures. This is the first randomized controlled study to examine the efficacy and feasibility of lumbar-type HAL in patients with chronic heart failure. If the results confirm beneficial effects in the outcomes of patients with heart failure, this study will add more evidence in support of the use of the lumbar-type HAL as an effective tool in new cardiac rehabilitation programs.

Sign in / Sign up

Export Citation Format

Share Document